Lifecome Biochemistry Co Ltd Market Cap ($415.96 Million)
Market Cap & Net Worth: Lifecome Biochemistry Co Ltd (002868)
Lifecome Biochemistry Co Ltd market cap. Lifecome Biochemistry Co Ltd (SHE:002868) has a market capitalization of $415.96 Million (CN¥2.84 Billion) as of November 6, 2026. Listed on the SHE stock exchange, this China-based company holds position #12905 globally and #3768 in its home market, demonstrating a -3.89% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lifecome Biochemistry Co Ltd's stock price CN¥18.29 by its total outstanding shares 155415837 (155.42 Million). Also see Lifecome Biochemistry Co Ltd (002868) cash conversion ratio for how efficiently the company converts equity into cash flow.
Lifecome Biochemistry Co Ltd Market Cap History (2017–2026)
Lifecome Biochemistry Co Ltd market cap history from 2017 to 2026. Data shows growth from $405.05 Million to $415.96 Million (1.50% CAGR). Check today's stock price for Lifecome Biochemistry Co Ltd for real-time trading data and today's change.
Lifecome Biochemistry Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lifecome Biochemistry Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Lifecome Biochemistry Co Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.48x
Lifecome Biochemistry Co Ltd's market cap is 1.48 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $405.05 Million | $375.41 Million | $85.92 Million | 1.08x | 4.71x |
| 2018 | $251.15 Million | $344.29 Million | $74.69 Million | 0.73x | 3.36x |
| 2019 | $306.93 Million | $303.76 Million | $56.97 Million | 1.01x | 5.39x |
| 2020 | $299.52 Million | $308.15 Million | $43.21 Million | 0.97x | 6.93x |
| 2021 | $250.85 Million | $363.39 Million | -$26.04 Million | 0.69x | N/A |
| 2022 | $1.21 Billion | $329.85 Million | -$121.94 Million | 3.66x | N/A |
| 2023 | $483.50 Million | $507.00 Million | -$221.82 Million | 0.95x | N/A |
| 2024 | $454.16 Million | $649.37 Million | -$444.86 Million | 0.70x | N/A |
| 2025 | $766.64 Million | $516.58 Million | -$139.26 Million | 1.48x | N/A |
Competitor Companies of 002868 by Market Capitalization
Companies near Lifecome Biochemistry Co Ltd in the global market cap rankings as of November 6, 2026. Also see Lifecome Biochemistry Co Ltd asset portfolio for a full breakdown of the balance sheet.
Key companies related to Lifecome Biochemistry Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #181 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $549.04 |
| #373 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $930.67 |
| #415 | CSL Ltd | AU:CSL | $67.74 Billion | AU$197.34 |
| #503 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $258.38 |
Market Capitalization of Lifecome Biochemistry Co Ltd (2017–2026)
Market capitalization of Lifecome Biochemistry Co Ltd from 2017 to today. Between 2017 and today, Lifecome Biochemistry Co Ltd's market cap moved from $405.05 Million to $ 415.96 Million, with a yearly change of 1.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥415.96 Million | -45.74% |
| 2025 | CN¥766.64 Million | +68.80% |
| 2024 | CN¥454.16 Million | -6.07% |
| 2023 | CN¥483.50 Million | -59.95% |
| 2022 | CN¥1.21 Billion | +381.32% |
| 2021 | CN¥250.85 Million | -16.25% |
| 2020 | CN¥299.52 Million | -2.41% |
| 2019 | CN¥306.93 Million | +22.21% |
| 2018 | CN¥251.15 Million | -38.00% |
| 2017 | CN¥405.05 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Lifecome Biochemistry Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $415.96 Million USD |
| MoneyControl | $415.96 Million USD |
| MarketWatch | $415.96 Million USD |
| marketcap.company | $415.96 Million USD |
| Reuters | $415.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lifecome Biochemistry Co Ltd
Lifecome Biochemistry Co.,Ltd. engages in research, development, production, and sales of veterinary drugs in China. It offers probiotics and green microbial functional additives; biopesticides, biofertilizers, and pesticide formulations; and food additives. The company was founded in 2003 and is based in Pucheng, China.